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Abstract:
Cells need proteins to carry out molecular functions, but proteins can become damaged or
misfolded, which inhibits their function and can cause aggregation. Misfolded protein
aggregation is associated with degenerative diseases in mammals. In Eukaryotic cells,
chronically misfolded proteins can be destroyed by the Ubiquitin Proteasome System (UPS) as a
way to prevent aggregation and disease. For my thesis work, I have investigated two pathways
that participate in the UPS.
First, I investigate Endoplasmic Reticulum Associated Degradation (ERAD), a UPS
pathway is active in the Endoplasmic Reticulum (ER) of eukaryotic cells. ERAD is well
characterized in Saccharomyces cerevisiae (yeast), but has only recently been studied in
multicellular systems. The Dahlberg Lab has begun to characterize the ERAD pathway
regulating GLR-1, a glutamate receptor in the neurons of Caenorhabditis elegans. GLR-1 is a
substrate for the E3 Ubiquitin ligase HRDL-1 in ERAD, and it accumulates in the cell when
HRDL-1 is non-functional. We characterize location of accumulating GLR-1 in the absence of
HRDL-1 with organelle level resolution. By determining the glycosylated state of GLR-1, we
find that additional GLR-1 remains in the ER when HRDL-1 is nonfunctional. Our finding
suggests that GLR-1 is likely accumulating in a misfolded state when ERAD is impaired.
Second, we begin to characterize another branch of the UPS that acts in the nucleus of
Eukaryotic cells. A nuclear UPS pathway has also been investigated in S. cerevisiae, but a
homologous pathway in a multicellular system has not been characterized. Using C. elegans, we
demonstrate that aggregation prone proteins accumulate in the nuclei of body wall muscle cells,
and that nuclear accumulation increases between the second and third day of the worm’s life.
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Studying protein quality control in C. elegans can help us understand how it might
function more generally in metazoan systems. Human diseases involving protein aggregation,
such as Parkinson’s, Alzheimer’s, Huntington’s, and other neurodegenerative diseases, highlight
the importance of protein quality control mechanisms in metazoan systems. Learning about
protein quality control in a C. elegans may help us understand protein aggregation diseases in
humans.
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Introduction
Protein Synthesis and Folding
Proteins carry out necessary biological functions in cells. Proteins are made of amino
acids covalently linked together via peptide bonds to form long chains called polypeptides. There
are 20 commonly occurring amino acids, which can be categorized as polar or non-polar. The
sequence of amino acids in the chain is known as the primary structure of the protein (Figure
1A). The pattern of polar and non-polar amino acids in the primary structure leads to secondary
structure elements such as α-helices and β-sheets that have polar and non-polar regions (Figure
1B). Nonpolar regions of a nascent protein are driven together by the hydrophobic effect (Figure
2). The protein reaches a single low energy conformation known as the native structure, where
hydrophobic residues are hidden from the aqueous environment of the cell (Figure 1C). Other
proteins, called molecular chaperones, can also be recruited to direct the polypeptide into its
fully-folded state (Figure 3). Unique native conformations allow proteins to have specific
functions, allowing cells to accomplish a wide variety of tasks.

Figure 1. Protein structure and folding patterns in an aqueous environment.
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Figure 2. The hydrophobic effect. Clathrate
structures made of hydrogen bonds between
water molecules surround nonpolar,
hydrophobic molecules. (A) Two separate
hydrophobic molecules require more water to
form the clathrate structure. (B) When two
hydrophobic molecules move together, water
molecules between them are released. The
resulting increase in entropy (disorder) of the
aqueous environment is energetically favorable.

Figure 3. The protein folding funnel. Unfolded,
unstable proteins at the top of the funnel fold into
lower energy states through a series of intermediate
steps. Molecular chaperones help fold proteins into
their native state (green tip of the funnel) and prevent
proteins from irreversibly forming amorphous
aggregates, oligomers, or amyloid fibrils (red tips of
the funnel). (Figure adapted from Hartl, Bracher, and
Hayer-Hartl 2011).

Proteins Can Become Misfolded
Some synthesized proteins are not folded correctly as a consequence of environmental
conditions in the cell, erroneous modification, or mutations in the gene that codes for the protein,
among other factors (Pedersen and Heegaard 2013). Up to 30% of synthesized proteins never
achieve their naturally folded state and cannot function normally (Schubert et al. 2000). In a
misfolded or unfolded state, hydrophobic residues that normally make up the interior of a
correctly folded protein are exposed to the aqueous environment of the cell. This is
thermodynamically unfavorable and can result in hydrophobic regions of multiple different
proteins clumping together in a process called aggregation. The formation of aggregates reduces
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contact between hydrophobic residues and the aqueous environment, which is energetically
favorable and can make protein aggregates extremely stable structures that are highly resistant to
refolding with molecular chaperones (Figure 3).
Aggregation can be extremely toxic to cellular health. Two common human
neurodegenerative diseases, Alzheimer’s disease (AD) and Huntington’s disease (HD), are
associated with protein aggregation and demonstrate the serious consequences of protein
misfolding. AD is characterized by the loss of cortical brain tissue and presence of amyloid
plaques and neurofibrillary tangles, forms of protein aggregation (Ferri et al. 2005). Patients with
AD suffer from severe memory loss and lose the ability to carry out everyday tasks. A defining
characteristic of HD is the formation of inclusion bodies (protein aggregates) in the nucleus of
cells in the central nervous system (Arrasate and Finkbeiner 2012). As a result, HD patients
suffer from a loss in motor control and balance. Neurodegenerative diseases are late onset; for
example, about 1% of 60 year olds are afflicted with AD, with incidence doubling every five
years, so that 30-50% of people over 85 years have AD (Pedersen and Heegaard 2013). AD and
HD both exemplify the toxicity of protein aggregation and highlight the importance of protein
quality control mechanisms in the cell that remove damaged and misfolded proteins.
The Ubiquitin Proteasome System Degrades Misfolded Proteins
The ubiquitin proteasome system (UPS) is a protein quality control mechanism that is
responsible for degrading chronically misfolded proteins in eukaryotic cells. For a misfolded
protein to be degraded by the UPS, a small protein called ubiquitin must be covalently added to
the misfolded protein via Lysine, or less frequently Serine or Threonine, residues (Figure 4).
Adding ubiquitin requires a cascade of reactions involving E1, E2, and E3 ubiquitin ligase
proteins. An E1 ligase covalently binds one ubiquitin molecule and activates its C-terminal
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Glycine amino acid residue in an ATP dependent manner. This activated form of ubiquitin is
then transferred to an E2 ligase, and E3 ligase then catalyzes the transfer of the ubiquitin
molecule from the E2 to the target protein (Figure 4). In most organisms, there is one known E1
ligase, dozens of E2 ligases, and hundreds of E3 ligases. Because there is a multitude of E3
ligases that associate with specific target proteins, ubiquitin can be transferred with high
specificity. Additional ubiquitin can be added to the misfolded protein in a chain, with each new
ubiquitin protein linked to a Lysine amino acid residue on the subsequent ubiquitin (Hershko and
Ciechanover 1998). There are 7 different Lysine residues on ubiquitin that can be utilized as
links in polyubiquitylation, and specific linkage patterns signal for specific protein fates. The
UPS predominantly uses the Lysine-48 linked polyubiquitin chains, which is a signal that the
tagged protein must be degraded in the 26S Proteasome (Coux, Tanaka, and Goldberg 1996).

Figure 4. The Ubiquitin Proteasome System. A Cysteine residue on the E1 ligase binds
ubiquitin in an ATP-dependent manner. The ubiquitin is then transferred to a Cysteine
residue on an E2 ligase. An E3 ligase with its target substrate binds the E2 with ubiquitin,
and the ubiquitin is transferred to the misfolded substrate. A polyubiquitin chain with
Lysine-48 linkages is a signal for proteasomal degradation. (Maupin-Furlow 2012)

The polyubiquitylated misfolded target protein must be sent to the 26S proteasome for
degradation. Although the mechanisms are largely uncharacterized in metazoan systems, the
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degradation pathway of ubiquitylated proteins in the Endoplasmic Reticulum (ER) has been
researched in yeast. A multi-protein complex that includes cell division control protein 48
(CDC48), ubiquitin fusion degradation protein 1 (UFD1), and nuclear localization protein 4
(NPL4) is involved in extracting polyubiquitylated substrates from the ER membrane and
transferring it to the 26S proteasome (Baek, Kim, and Rao 2011; Jarosch et al. 2002; Baek et al.
2013; Wolf and Stolz 2012).
The 26S proteasome itself is comprised of three major particles – one core particle and
two regulatory particles. The regulatory particles, which cap the two ends of the cylindrical core
particle, are comprised of proteasome regulatory particles (RPNs), some of which deubiquitinate the substrate so that ubiquitin molecules can be reused. The inside of the core
particle contains 28 protein subunits with catalytic sites that hydrolyze (break) the peptide bonds
of the substrate protein into short peptides to be recycled as amino acids, which can be used for
protein synthesis or generating metabolic intermediates (Bedford et al. 2010).
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Part One: Protein Degradation at the Endoplasmic Reticulum
Background
Transmembrane Protein Maturation - Synthesis and Folding
Transmembrane proteins comprise a diverse class of proteins imbedded in the
membranes of a cell. They are important for cell to cell communication by serving as signal
receptors, among many other functions. In Eukaryotic cells, membrane proteins are synthesized
in the Endoplasmic Reticulum (ER), a membranous organelle that is contiguous with the nuclear
membrane. As membrane proteins mature in the ER, they receive modifications to help them to
fold and mature correctly. An important modification is the addition of sugar moieties to
Asparagine (N) amino acid residues, a process called glycosylation. These tags form a “glycocode” which displays the folding status, allowing unfolded and folded proteins to be sorted
accordingly (Alberts et al. 2002; Amm, Sommer, and Wolf 2014). Specific N-linked glycan tags
are unique to proteins found in the ER, although additional glycosylic modifications are made
throughout the lifespan of the protein at various locations in the cell. In addition to glycosylation,
ER processing includes binding by molecular chaperone proteins to help nascent proteins fold
correctly, and the formation of covalent disulfide bonds between Cysteine amino acid residues
help stabilize the protein in its folded conformation. Folded, functional membrane proteins leave
the ER to further mature in the Golgi Apparatus, and undergo further trafficking to other regions
of the cell, including the plasma membrane.
Unfolded Protein Response (UPR)
A variety of stressors can cause protein misfolding or unfolding. One well characterized
stress is heat-shock, where an increase in temperature destabilizes the non-covalent bonds in a
folded protein and causes it to lose its native conformation. When protein folding and re-folding
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in the ER becomes too inefficient, unfolded proteins build up and the unfolded protein response
(UPR) is activated. In the ER, three different membrane bound signaling proteins are responsible
for detecting high quantities of unfolded protein: the inositol requiring enzyme-1 (IRE1), the
PRKR-like ER kinase (PERK), and activating transcription factor-6 (ATF-6) (Bravo et al.
2013)(Figure 5). In unstressed conditions, each sensor is bound to the molecular chaperone BiP
(Binding Protein). When misfolded protein concentrations increase in the ER, BiP is released
from the luminal (interior) domain of each sensor. This release causes conformational changes in
the cytosolic domain of the sensors, activating UPR pathways. Through a variety of molecular
interactions, these pathways attenuate overall protein translation rates, cause a genetic response
that results in ER expansion, and increase production of chaperone and protein degradation
machinery, which helps the cell survive by reducing the concentration of misfolded proteins
through refolding or by degrading terminally misfolded proteins (Bravo et al. 2013).

Figure 5. The Unfolded Protein Response. The initiation of PERK, IRE1, and ATF6 ER stress signaling
pathways depends on Binding Protein (BiP) dissociation from the luminal domain of each signaling protein.
Downstream, potent transcription factors upregulate protein folding and degradation machinery, including ERAD
components. (Image from Bravo et. al. 2013)
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Endoplasmic Reticulum Associated Degradation (ERAD)
ER associated degradation (ERAD) is an ER-specific branch of the UPS that is activated
by the UPR. When BiP chaperones dissociate from the luminal domain of IRE-1 sensors during
ER stress, IRE-1 subunits dimerize, and autophosphorylation causes conformational changes that
activate an RNA cleaving active site in the cytosolic domain. This site modifies mRNA
transcripts that code for potent transcription factors, including XBP-1 that activate the synthesis
of ERAD machinery, including E1, E2, and E3 proteins (Kadowaki and Nishitoh 2013) (Figure
5).
ERAD has been well characterized in yeast. The E3 ubiquitin ligase DOA10 functions
with E2 ligases UBC6 and UBC7 to polyubiquitylate misfolded substrates using Lysine-48
linkages. CDC48 is involved in the extraction and of DOA10 ubiquitylated substrates from the
ER membrane and subsequent translocation to the 26S proteasome for degradation (Weber et al.
2016; Carvalho, Goder, and Rapoport 2006). Another ERAD E3 ligase called HRD1 has also
been characterized in yeast. Although both DOA10 and HRD1 function at the ER, they are not
functionally redundant. HRD1 targets substrates that are misfolded in their luminal or
transmembrane domains, while DOA10 generally targets proteins that are misfolded in their
cytosolic domains (Zattas et al. 2016). ERAD has also been studied in human cell culture, though
to a lesser extent. MARCH6 is the human ortholog to yeast DOA10, and both MARCH6 and
DOA10 both contain a C-terminal element (CTE) that is required for DOA10/MARCH6 to
function (Zattas et al. 2016).
Caenorhabditis elegans as a model organism
Although ERAD has been characterized in yeast, a single celled eukaryotic organism, the
Dahlberg Lab is interested in knowing how it functions in complex multicellular organisms. To
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do this, we have opted to use C. elegans, a microscopic nematode worm. The three-day
reproductive lifecycle of C. elegans is ideal for performing many experiments in rapid
succession. In addition, they are non-intensively maintained on a bed of E. coli bacteria and agar,
and they are predominantly hermaphroditic and capable of self-propagating genetic clones,
which is useful for genetic studies.
A useful aspect of C. elegans as a model organism is the relative ease of studying celltype specific biology in living organisms. They have exactly 959 somatic cells, all of which are
mapped for tissue type and location, and many of which are well studied (Corsi 2015). C.
elegans was the first multicellular organism to have its genome completely sequenced, and 6080% of human genes have an ortholog in C. elegans, so research using C. elegans has relevance
to human biology (Corsi 2015). Specifically, the proteins relevant to this study have orthologues
in humans, allowing us to infer potential protein-protein interactions in humans based on our
findings in C. elegans (Table 1). Many cutting-edge molecular biology tools that are used in
yeast research can also be used on C. elegans. Their transparent cuticle allows for effective
microscopy using fluorescently-labelled fusion proteins and reporter genes, and current genomic
editing tools like CRISPR can be used for genetic experiments. In addition, RNA channels in the
gut of C. elegans allows researchers to conduct RNA interference (RNAi) experiments (Corsi
2015).
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Orthologous Protein
C. elegans

Humans
(H. sapiens)

HRD1
DOA10

HRDL-1
HRD-1
MARC-6

Gp78
HRD1
MARCH6

E2 Ligase
(ERAD)

UBC6
UBC7

UBC-6
UBC-7

UBE2J1
UBE2G1

Glutamate
Receptor

--

GLR-1

GLUR1

Membrane
Protein
Extraction

CDC48

CDC48.1
CDC48.2

p97

Function
E3 Ligase
(ERAD)

Yeast
(S. Cerevisiae)

Table 1. Protein homology in yeast, C. elegans, and humans. Data organized from www.wormbase.org.

Our lab has begun to characterize ERAD in a multicellular organism, using C. elegans.
We have chosen to study the well characterized membrane protein GLR-1 as an ERAD substrate.
GLR-1 is a transmembrane glutamate receptor that is essential for food seeking behavior and is
expressed in a subset of interneurons in C. elegans. Prior to my work, the Dahlberg Lab had
already begun to characterize how GLR-1 is regulated by ERAD. We have studied the quantity
and localization of GLR-1 by using genetic tools to fuse it Green Fluorescent Protein (GFP),
creating a single polypeptide chain (GLR-1::GFP). This allows us to use fluorescent microscopy
to visualize GLR-1 in living C. elegans and to conduct biochemical assays which help us
quantify GLR-1 abundance.
The E3 ligase HRDL-1 appears to be involved in the polyubiquitylation of GLR-1.
Microscopic and biochemical analysis suggest that GLR-1 abundance increases when functional
HRDL-1 is not present (Witus 2016, unpublished). This suggests that GLR-1 may be a substrate
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for HRDL-1 in ERAD. However, it remains unclear if the additional GLR-1 in hrdl-1 mutant
animals is misfolded or if it resides at the ER.
Research Question:
The purpose of this study is to identify the location of GLR-1 aggregation in the absence
of functional HRDL-1 with organelle level resolution. We hope to distinguish if GLR-1 is
accumulating in the ER, or if it is allowed to leave the ER and accumulate elsewhere.
Hypothesis:
ERAD functions to degrade misfolded proteins in the ER, so we hypothesize that
disrupting the GLR-1 ERAD pathway would result in GLR-1 accumulation at the ER, likely in a
misfolded state. In order for a protein to be exported from the ER, it needs to display an ER exit
signal that can be recognized by proteins associated with COP vesicles (Alberts et al. 2002).
These signals include specific glycosylations that indicate the protein is correctly folded. A
correctly folded protein will receive glycosylation modifications and be exported to continue
maturation at the Golgi Apparatus, where it receives different glycosylations. We think that we
will find ER-type glycosylations on a larger proportion of GLR-1 in C. elegans with no
functional HRDL-1, which would suggest that accumulated GLR-1 is in the ER membrane and
likely misfolded.
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Methods
Worm Strains
FJ354: glr-1::gfp(nuIs24)(IV)
This strain is a control for GLR-1 abundance with normal (wild-type, WT) ERAD
function. It also contains an integrated transgene of glr-1 with a near C-terminal fusion to
green fluorescent protein (GFP), which we use as an antigen in a western blot assay
(described below).
FJ864: glr-1::gfp(nuIs24)(IV);hrdl-1(gk28)(I)
This strain contains a 1981bp deletion in the hrdl-1 gene. This significant deletion
effectively knocks out HRDL-1, disrupting the ERAD pathway for GLR-1. This strain
also contains the integrated transgene glr-1::gfp, allowing it to be detected with the same
antibodies as the control strain in a western blot assay.
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Figure 6. Experimental Overview
A. Protein Preparation. Membranes and
membrane-bound proteins isolated from FJ864
(hrdl-1 mutant) whole worm lysate are incubated
with the enzyme Endoglycosidase H (Endo H).
Endo H selectively cleaves N-linked glycosylation
structures unique to the ER and early Golgi but
leaves glycosylations acquired later in the Golgi
uncut. (Adapted from Garland Science 2008).

Endo H
resistant

Western Blot

FJ864 (gk28)

137 kD

FJ354 (WT)

Anti-GFP

B. Protein Detection. The Endo H treated
membrane proteins are then denatured,
separated by molecular weight with SDSPAGE, and transferred to a nitrocellulose
membrane (western blot). Using a
sequence of antibodies that are (1) antiGFP and (2) chemiluminescent, GLR1::GFP protein can be visualized and
quantified. Performing the procedure in
parallel with FJ354 (WT) whole worm
lysate provides a basis for relative
quantification. Negative (no enzyme) and
positive (PNGaseF) glycosylation-cleaving
control reactions flank Endo H treated
membrane proteins. The upper (uncleaved) to lower (cleaved) band density
ratio in the Endo H treated GLR-1::GFP
can be compared to analyze the relative
amount of GLR-1 at the ER membrane.

Endo H
sensitive

Endo H resistant (Golgi)

Endo H sensitive (ER)
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To determine if GLR-1 is accumulating at the ER when a hrdl-1 mutation compromises
the GLR-1 ERAD pathway, we analyzed the glycosylated state of GLR-1 proteins in worms with
and without a hrdl-1 mutation. The glycosylation patterns of proteins at the ER are unique
compared to those on proteins that have left the ER and continued to mature. Given this, we
adapted a three-part protocol: (1) Isolate the membrane proteins from a population of worms, (2)
digest the membrane proteins with a selective glycosidase enzyme, and (3) use a Western blot to
visualize and quantify GLR-1::GFP (Figure 6) (original protocol adapted from Chun et al. 2008).
Membrane Isolation
Worms grown in a liquid culture are lysed with freeze-thaw cycles. The lysis solution is
treated with sonication to break open the membranes of cells. A low velocity spin eliminates
worm cuticle (protective outer layer) and any un-lysed material, followed by a high velocity spin
that separates membrane with membrane-bound proteins from cytosol and cytosolic components.
Glycosidase Digest
Because glycosylation modifications given to
proteins at the ER membrane are modified as proteins
move to other organelles, detection of ER specific
modification can describe where a protein was at the
time of lysis. Endoglycosidase H (Endo H) is an

Figure 7. Endoglycosidase H cleaves β(1,4)
linkages between two GlcNac subunits near the
base of ER-type the glycosylations. (Figure
from Sigma-Aldrich)

enzyme that recognizes and shortens (cleaves) only N-linked glycosylations on proteins present
in the ER, changing their overall molecular weight (Figure 7). Thus, GLR-1 proteins with ER
modifications will have a smaller molecular weight than other GLR-1 proteins (at the Golgi, cell
membrane, etc.) after the Endo H digest (Figure 6B).
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Western Blot
A Western blot is used to visualize and quantify specific proteins from the lysate. Endo H
treated membrane proteins are solubilized with Sodium Dodecyl Sulfate (SDS), which associates
with hydrophobic regions on proteins and negatively charges them, and beta-mercaptoethanol
(βME) which reduces (breaks) disulfide bonds. This denatures the tertiary and secondary
structure of the membrane proteins, breaking them down to their primary structure. The
denatured, negatively charged membrane proteins are loaded into a polyacrylamide gel, and an
electric current is passed through the gel, causing them to migrate with the current. Smaller
proteins migrate through the gel matrix faster than large proteins, separating all membrane
proteins by size. The membrane proteins are then transferred from the gel and onto a
nitrocellulose membrane. To detect the GLR-1::GFP fusion proteins on the membrane, anti-GFP
antibodies are washed over the membrane and attach to GFP. A secondary antibody with
chemiluminescent tags attach to the first antibody, and the protein can be visualized and
quantified (Figure 6B).
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Results

1.4

Density Ratio

1.2
1
0.8
0.6
0.4
0.2
0

WT to detect GLR-1::GFP
hrdl-1
Figure 8. Western blot probed with α-GFP antibody
fusion protein in WT (FJ354) and
hrdl-1 mutant (FJ864) worm strains. Quantification of the Endo H resistant to Endo H sensitive protein ratio
reveals that a greater proportion of GLR-1::GFP is found at the ER membrane in hrdl-1 mutants compared to
WT (n=2).
To quantify my western blot data, I measured the pixel intensity of the upper (Endo H
resistant) and lower (Endo H sensitive) bands in the Endo H treated lanes and found the upper to
lower band density ratio. I found that a higher proportion of GLR-1::GFP protein is sensitive to
Endo H cleavage in C. elegans without functional E3 ubiquitin ligase HRDL-1 (WT SD=0.069,
hrdl-1 SD=0.024, n=2). GLR-1::GFP is only sensitive to Endo H when it has ER-type
glycosylations; thus, I find that a higher proportion of GLR-1::GFP is present in the ER
compared to the rest of the cell when the hrdl-1 gene is mutated.
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Discussion
The current model predicts that ERAD substrates will remain at the ER when ERAD is
compromised. Thus, I predicted that GLR-1, an ERAD substrate, would remain at the ER when
the E3 responsible for targeting misfolded GLR-1 for degradation, HRDL-1, is non-functional.
The data I collected indicates that a higher proportion of GLR-1 has ER glycosylations in C.
elegans without functional HRDL-1, suggesting that more GLR-1 resides at the ER when ERAD
is compromised. This data supports the current model.
The additional GLR-1 protein in hrdl-1 mutants is likely misfolded. The Dahlberg lab
conducts behavioral assays using worms with E3 mutations. One phenotype associated with a
glr-1 mutation in C. elegans is a decrease food seeking behavior. In the absence of diacetyl, an
odorant released by their food source, worms will reverse and turn another direction to continue
food seeking. This is called a “reversal,” and the frequency of reversals depends on
glutamatergic signaling in the interneurons using GLR-1. Glr-1 mutants reverse less often
compared to wild-type worms. Worms without functional HRDL-1 have slightly lower reversal
rates rather than an increased reversal rate, even though we find that GLR-1 is more abundant in
these animals (Chapman, unpublished; Witus, unpublished). Combined with my finding that
additional GLR-1 resides at the ER and not at the synapse in worms without functional HRDL-1,
we hypothesize that additional GLR-1 is likely misfolded.
Through studying ERAD in the nervous system of C. elegans, a Eukaryotic multicellular
organism, we can begin to understand how protein degradation systems function in higher
eukaryotes, such as humans. Up to 30% of synthesized proteins never achieve their naturally
folded state and cannot serve their designated purpose (Schubert et al. 2000). If not degraded,
misfolded proteins can form toxic protein aggregates in the cell which may lead to cell death.
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This phenomenon is observed in neurodegenerative diseases like Alzheimer’s and Huntington’s.
Ongoing and future studies will further characterize the GLR-1 ERAD pathway by investigating
the effects of E2 ligase ubc-6 and ubc-7 mutations on the localization and quantity of GLR-1 in
interneurons. Additionally, the Dahlberg lab has begun studies of GLR-1 ERAD regulation under
ER stress with high rates of protein misfolding. By increasing the rate of protein misfolding at
the ER, we can determine which proteins appear to have the most important role in ER stress
response.
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Part Two: Protein Degradation at the Nucleus
Background
The UPS acts at the Nucleus
While endoplasmic reticulum (ER)-associated degradation pathway has been well
characterized, the ubiquitin-proteasome system (UPS) of the nucleus has only recently been
characterized in yeast. Dr. Rich Gardner and his lab at the University of Washington discovered
a degradation pathway that relies on the E3 ubiquitin ligase San1 to identify and ubiquitinate
misfolded proteins at the nucleus (Gardner, Nelson, and Gottschling 2005). Like E3 ubiquitin
ligases that act at the ER, San1 contains a RING (Really Interesting New Gene) domain that
catalyzes the transfer of ubiquitin from E2 ubiquitin conjugating enzymes to the misfolded
protein. Unlike ER-associated E3s, the San1 RING domain contains a nuclear localization
sequence (NLS) that is necessary and sufficient for San1 to be localized to the nucleus (Gardner,
Nelson, and Gottschling 2005) (Figure 9).

Figure 9. The San1 protein RING domain. The larger black letters represent Cysteine and Histidine amino
acid residues that bind Zinc ions for conformational stability. The large gray letters represent the bipartite
nuclear localization sequence, while the entire sequence is underlined (Figure adapted from Gardner,
Nelson, and Gottschling 2005)

In ERAD, Cdc48 is required to extract membrane proteins from the ER membrane due to
the insolubility of the transmembrane domains of the substrate. In the nucleus, Cdc48 is
necessary to relocate some, but not all, San1 targeted misfolded proteins to the nuclear
proteasome; the more insoluble the misfolded protein is, the more dependent it is on Cdc48 for
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translocation to the proteasome (Gallagher, Clowes Candadai, and Gardner 2014). San1
recognizes misfolded proteins based on the length of exposed hydrophobic sequences. A
sequence of five hydrophobic amino acid residues or longer is sufficient for San1 recognition,
and shorter sequences are less efficiently recognized and degraded (Fredrickson, Gallagher, et al.
2013).
Identifying a San1 Analogous Metazoan PQC Mechanism
The primary structure of San1 is poorly conserved, so using virtual bioinformatics search
tools to identify orthologues in other organisms in is largely inefficient. However, potential
candidates for San1 orthologues in humans were identified using two unique characteristics: (1)
San1 has comparatively few Lysine amino acid residues outside of its RING domain, and (2)
San1 is highly disordered outside of its RING domain (Fredrickson, Clowes Candadai, et al.
2013; Boomsma et al. 2016)(Figure 10). Ten possible candidates for San1 orthologues have also
been suggested in C. elegans using these two parameters (Rich Gardner, personal
communication). The identified San1 orthologues have not yet been tested for involvement in
PQC activity in the nucleus.
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Figure 10. (A) San1 is highly disordered
in the N- and C- terminal regions,
making sequence homology very low
between potential orthologues. However,
the high degree of disorder itself can be
used to identify potential orthologues.
San1 contains very few Lysine (K)
residues outside of the RING domain,
which is another defining characteristic
that is used to find orthologues. (B)
Adding Lysine (K) residues into the Cor N- terminal regions of San1 can cause
autoubiquitination, where San1 transfers
ubiquitin to itself rather than the target
protein, resulting in San-1 degradation
rather than substrate degradation. (Figure
from Fredrickson et al. 2013)

Based on biochemical evidence from the yeast San1 pathway, San1 substrate
polypeptides were engineered in order to test potential San1 orthologues in human cells. These
polypeptides include a chain of Isoleucine amino acid residues, a nuclear localization sequence
(NLS), and green fluorescent protein (GFP). Isoleucine is non-polar and highly insoluble, so
attaching a chain of it to GFPNLS makes the polypeptide aggregation prone which signals for
degradation of the protein. The NLS causes the protein to be translocated to the nucleus, and
GFP allows the construct to be visualized. This substrate is degraded in the nucleus of human
cells, but the proteins involved in the pathway have not been identified (Morimoto and Shibata,
unpublished).
In human patients, symptoms of neurodegenerative disease becomes more common with
age (Pedersen and Heegaard 2013). This suggests that PQC becomes less effective with age,
either because protein misfolding increases or because PQC mechanisms function more poorly
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over the lifespan of an individual. This age-dependent phenotype should also occur in a model
system if the molecular mechanisms are conserved.
Research Question / Rationale
The primary goal of this study was to engineer a model system in which we can study
nuclear PQC mechanisms. Using C. elegans, a multicellular eukaryotic organism, may help us
understand how it functions in higher Eukaryotes (such as humans). Through this model, we
investigated if (1) a San1 substrate behaves similarly in C. elegans as it does in a yeast model,
and (2) if nuclear PQC shows significant loss of efficacy over the lifespan of C. elegans. Human
neurodegenerative diseases typically have late onset; for example, Alzheimer’s disease incidence
is about 1% in 60-year-olds and doubles every 5 years, demonstrating that PQC mechanisms
may become less effective over time (Pedersen and Heegaard 2013). If nuclear PQC mechanisms
are conserved from C. elegans to humans, we predict that protein homeostasis in the nucleus will
become worse over time. The Dahlberg Lab’s research on ER-associated degradation provides
evidence that PQC mechanisms at the ER are conserved from yeast to C. elegans. In addition,
PQC mechanisms in the mitochondria and ER are conserved across many eukaryotic organisms,
including yeast and humans (Bohovych, Chan, and Khalimonchuk 2015; Ruggiano, Foresti, and
Carvalho 2014). Thus, it is reasonable to predict that a nuclear protein quality control mechanism
is also conserved from yeast to C. elegans.
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Methods
Making a Model for Nuclear PQC
We used the same blueprint for a San1 substrate engineered polypeptide sequence used in
yeast to generate a C. elegans analog. Using a circular piece of DNA (plasmid), we placed the
sequence for the San1 substrate under the control of a myosin promoter that is active in the body
wall muscle of C. elegans (Figure 11).

(Isoleucine)5

Figure 11. Plasmid map. The myo-3 promoter is shown in blue, just upstream of the SV40 NLS, a viral
nuclear localization sequence. GFP exons are shown in green, and the location of 5 Isoleucine codons at
the terminus of the GFP sequence are indicated with the red arrow.
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This method of genetic engineering in model organisms is extremely common. A
promoter is a sequence of DNA to which transcription factors bind and regulate the transcription
of the downstream gene. As a result, select genes are actively transcribed in specific cell types.
The myosin-3 protein is an isoform of myosin, a protein necessary for muscle contraction that is
expressed in the body wall muscle of C. elegans (Okkema et al. 1993). By putting our construct
downstream of the myosin-3 promotor, we can express our protein in the body wall muscle of C.
elegans. The plasmid DNA is injected into the gonad of an adult worm, which allows it to be
passed on to future generations (Evans 2006) (Figure 12). Dr. Irini Topalidou at the University of
Washington completed the microinjection of our plasmid.

Figure 12. Microinjection of Plasmid DNA into the distal arm of the gonad in C. elegans. The white point
represents the tip of the needle, and the arrows show the flow of injected DNA. At the injection site, there
is not yet a plasma membrane surrounding developing egg cells, so the plasmid can diffuse into nuclei with
a higher success rate (Image from Evans 2006)

Plasmid DNA is extrachromosomal, meaning it is not included in the genomic,
chromosomal DNA of the organism. Because the plasmid is not part of the genome, it has
variable inheritance. Thus, some offspring inherit many copies of the plasmid, while a fraction of
offspring inherit no copies. To mitigate this, we integrated our plasmid DNA into the genome of
C. elegans. We used UV light to induce double-stranded DNA breaks in the genomic and
plasmid DNA. Naturally occurring DNA repair pathways then integrate the plasmid DNA into
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the genome (Evans 2006) (Figure 13). Once the plasmid is integrated into the genome, it is
reliably passed to offspring through chromosomal DNA; offspring receive the same number of
copies of the plasmid in every cell.

Figure 13. Plasmid integration. UV light is directed at a population of worms containing the plasmid,
causing double-strand DNA breaks in both the plasmid DNA and genomic DNA in the nuclei of the worm.
The non-homologous end joining (NHEJ) DNA repair pathway can either (1) rejoin genome-genome
double strand breaks (non-integrant), or (2) join the plasmid and genome double stranded breaks,
integrating the plasmid DNA into the genome of the worm.

The probability that DNA plasmid will successfully integrate into the genomic DNA of
C. elegans is low, so a large scale screen must be conducted to find “integrant” worms. UV
exposed worms are picked individually onto their own plate and allowed to self-fertilize, creating
genetic clones of themselves. All offspring of an integrant parent will express the genetic
construct from the plasmid DNA, while a non-integrant parent will pass the un-integrated
plasmid to some (but not all) of the offspring. After screening dozens of potential integrants, I
identified one worm that contained a successfully integrated plasmid.
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We followed the same procedure to integrate a second plasmid with GFPNLS linked to a
Phenylalanine repeat instead of an Isoleucine repeat. Phenylalanine is another non-polar,
hydrophobic amino acid, and the repeat sequence was also used in yeast and human cell studies
to test for San1 orthologues (Fredrickson, Gallagher, et al. 2013). However, I failed to identify an
integrant strain of worms, yet found a strain with high penetrance – a high rate of inheritance
from parent to offspring – that I also continued to test for an aging phenotype, as described
below. Because the strain wasn’t a true integrant, the data is less reliable and is not included in
this manuscript.
Testing for Age-Dependent PQC Efficiency
To test if nuclear PQC becomes less effective over time, we use fluorescent microscopy
and western blotting. To ensure all worms we use are the same age in each age group, I
synchronized the lifecycle of a population of worms. Age synchronization is done by moving 10
egg-laying adult worms to a new plate, allowing them to lay eggs for 4 hours, then removing the
adults from the plate. The result is a population of offspring that are within 4 hours of the same
age. I imaged the heads and tails of 2, 3, and 6 day old worms and quantified the appearance of
green fluorescent nuclei in the body wall muscle. A worm with a functioning nuclear PQC
mechanism should have fewer green nuclei, as its cells are able to degrade the green glowing
aggregation prone polypeptide (GFPNLS::Ile5) efficiently. A worm with poorly functioning
nuclear PQC will have more green nuclei because its cells are unable to degrade the aggregation
prone polypeptide.
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Results
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Figure 14. Age-dependent nuclear accumulation of SAN1 substrate Ile5::GFPNLS. (A) Representative images
depicting tails of C. elegans with integrated Ile5::GFPNLS from each age group. Arrows indicate GFP
fluorescent nuclei. (B) Images were analyzed for number of GFP-fluorescent nuclei (n= images analyzed),
then grouped into categories based on number of nuclei observed (no nuclei, between 1 and 5 nuclei, and 6+
nuclei). Graph indicates percentage of total images in each category.
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We found that the number of nuclei with 1-5 GFPNLS::Ile5 inclusions increased between
images of 2 and 3 day old worms, but not between images of 3 and 6 day old worms (Figure
14B). Additionally, the number of images showing no nuclear GFPNLS::Ile5 inclusions decreased
sharply between 2 and 3 day old worms. Combined, this data suggests that the majority of worms
develop nuclear inclusions of GFPNLS::Ile5 between 2 and 3 day old worms.

Discussion
Imaging data suggests that the extent of nuclear accumulation of GFPNLS::Ile5 is age
dependent, suggesting that we have created a model to study nuclear PQC within an aging
paradigm. Although there were worms with many (6+) and no nuclear inclusions of GFPNLS::Ile5
in each age group, we find that more worms developed nuclear inclusions between 2 and 3 days
of age (Figure 14). It is not clear if this increase is caused by overloading properly functioning
nuclear PQC systems, or if nuclear PQC mechanism are beginning to malfunction. The lifespan
of C. elegans is about two weeks; by imaging worms that are closer to the end of their lifespan
(e.g. 10-14 days of age), we may see another increase in GFPNLS::Ile5 nuclear accumulation that
is a result of the nuclear PQC mechanism malfunction. This might contribute more useful
understanding of human age-related aggregation diseases.
Although the nuclear localization sequence in GFPNLS::Ile5 should cause the polypeptide
to localize in nucleus, we seek to develop a nuclear reporter to visualize the body wall muscle
cell nuclei. This will (1) confirm that the accumulations we see are in nuclei and (2) characterize
the accumulation in nuclei. While imaging, it appeared that some nuclei were diffuse with
GFPNLS::Ile5, while others had smaller, brighter puncta. This may be because some nuclei were
just out of the plane of focus, causing the GFP fluorescence to appear diffuse, or that some nuclei
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have more defined GFPNLS::Ile5 inclusions than others. To test this, we could express a
fluorescently tagged histone in the nuclei of the body wall muscle cells. Histones are DNA
binding proteins that help organize and regulate expression of chromosomal DNA in the nucleus.
If we fluorescently label histones, we will be able to visualize the nuclei of the worm, which will
help further characterize GFPNLS::Ile5 nuclear accumulation. If GFPNLS::Ile5 protein and
fluorescently labelled histones overlap in the same image, it provides evidence that GFPNLS::Ile5
is in the nucleus. The histone marker will also help determine which nuclei are in focus, which
will allow us to determine if some nuclei have more diffuse GFPNLS::Ile5 than others.
A western blot analysis can also be done to quantify the total amount of GFPNLS::Ile5 in
each age group. If biochemical analysis suggests that GFPNLS::Ile5 abundance increases from 2day to 3-day-old worms, it would agree with my microscopic imaging data, which suggests that
GFPNLS::Ile5 nuclear accumulation increases after the third day.
GFPNLS::Ile5 is a model substrate for San1 mediated degradation, and it has been used in
human cells to characterize yeast and human San-1 orthologues (Fredrickson, Gallagher, et al.
2013; Morimoto and Shibata, unpublished). Future studies will determine if San1 orthologues are
important for GFPNLS::Ile5 degradation in C. elegans using RNA interference (RNAi). The C.
elegans genome contains 152 proteins with RING domains, ten of which have some homology to
San1 (Kipreos 2005). We will knock out the expression of each protein using RNAi and
determine which knockouts cause an increase of nuclear accumulation of GFPNLS::Ile5. Previous
studies indicate that Cdc48 plays a role in nuclear degradation of highly insoluble misfolded
proteins in the nucleus of yeast (Gallagher, Clowes Candadai, and Gardner 2014). We will knock
out both copies of Cdc48 orthologues in C. elegans (cdc48.1 and cdc48.2) using RNAi and
determine if either play a role in nuclear protein quality control for GFPNLS::Ile5.
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Summary
Cells need proteins to carry out molecular functions, but proteins can become damaged or
misfolded. Misfolded proteins can become toxic to cells if they accumulate and aggregate, which
is evident in human neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and
Huntington’s, among others. The Ubiquitin Proteasome System (UPS) is a conserved pathway
that degrades terminally misfolded proteins, preventing aggregation and disease.
In the first part of my thesis work, I further characterized Endoplasmic Reticulum
Associated Degradation (ERAD), a UPS pathway that acts in the Endoplasmic Reticulum (ER)
of eukaryotic cells. The Dahlberg Lab had already begun to characterize the ERAD pathway
regulating GLR-1, a glutamate receptor in the neurons of Caenorhabditis elegans that is
necessary for reversal behavior. GLR-1 is a substrate for the E3 Ubiquitin ligase HRDL-1 in
ERAD, and it accumulates in the cell when HRDL-1 is non-functional (Witus, unpublished). One
would expect that an increase in GLR-1 abundance might cause worms to have increased
reversal behavior. However, behavioral analysis suggests that worms without functional HRDL1 reverse less often than wild-type, suggesting that accumulating GLR-1 is non-functional
(Chapman, unpublished). My work connects these two observations by suggesting that the
additional GLR-1 in worms without functional HRDL-1 is not localized to the synapse where it
functions, but is held at the ER, suggesting it may be misfolded. Altogether, our work
demonstrates that impairing ERAD causes a misregulation of important membrane proteins and
impairs cell function.
In the second part of my thesis work, I began to characterize a metazoan protein quality
control (PQC) mechanism that acts in the nucleus. A nuclear UPS pathway has been investigated
in S. cerevisiae (yeast) that requires the E3 San1, but a homologous pathway in a multicellular
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(metazoan) system has not been characterized. Using an aggregation prone target protein that is a
known target of a nuclear UPS in yeast (GFPNLS::Ile5), I helped generate a C. elegans model to
study metazoan nuclear PQC. With this model, I found evidence that GFPNLS::Ile5 accumulates
in the nuclei of body wall muscle cells, and that nuclear accumulation increases between the
second and third day of the worm’s life. These finding suggest that there is a nuclear PQC
mechanism in the nucleus of C. elegans that functions similarly to nuclear PQC in yeast, and
future work will use this model to continue research on proteins involved in the mechanism.
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Supplementary Materials: Protocols
Membrane Preparation Protocol:
1. Grow up 10-12 plates of worms, until plates are full but not starved. If starting with worm powder
from liquid culture, skip to step 5.
2. Wash 3 plates of worms serially with 1mL M9. Centrifuge at 4k RPM and pull off M9, being
careful not to pipette worms. Repeat until all plates are washed. Do a final rinse of the pellet by
adding 1.5mL M9 directly to the tube. After final spin, put the microfuge tube on ice to
consolidate worm pellet, and pull off all M9.
3. Add 100µL of freezing buffer (1:200 PMSF, 1:100 PI). Freeze in liquid nitrogen.
4. Using a mortar and pestle, grind the frozen pellet into a fine powder, making sure to keep the
worm powder frozen throughout the process. Put powder back into the microfuge tube, re-freeze
in liquid nitrogen. This can be stored at -80˚C, or continue on to step 5.
5. Thaw worm powder on ice, then add Buffer A (1:200 PMSF, 1:100 PI) for a total volume of
225µL.
6. Sonicate for 10 seconds at setting 3-4, then rest on ice for 1 minute. Repeat 5 times.
7. If needed, add Buffer A (1:200 PMSF, 1:100 PI) to 250µL.
8. Centrifuge at 7k RPM for 12 minutes at 4˚C.
9. Carefully take the supernatant and pipette into an ultracentrifuge tube. Balance tubes to be within
500µg of each other.
10. Centrifuge using Rotor 3 (AT120) at 82k RPM (303k rcf max) for 40 minutes at 4˚C.
11. Completely remove the liquid supernatant, and carefully obtain the waxy pellet. Dounce the pellet
into 100µL Buffer A (1:200 PMSF, 1:100 PI, 1:100 DTT) and pipette into a microfuge tube.

Endoglycosidase H Protocol:
1. Add 1.5 volumes of 2X Denature Buffer to P2 membranes.
2. Denature at 90˚C for 10 minutes.
3. Add 5 volumes of enzyme buffer to appropriate tubes:
a. Endo H:
1X Glycobuffer 3
1% NP-40
1:1000 β-ME
1:100 PMSF
1:1000 PI
b. PNGaseF:

4.
5.
6.
7.

1X Glycobuffer 2
1% NP-40
1:1000 β-ME
1:100 PMSF
1:1000 PI
Let rest on ice for 5 minutes, then add enzymes.
Incubate at 37˚C for 1-3 hours.
Add 1 volume 20% TCA to each tube. Let rest on ice for 10 minutes.
Centrifuge at 14k for 10 minutes. Remove as much supernatant as possible.
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8. Wash the pellet with 1.5mL acetone without disturbing it, then remove all acetone.
9. Add SDS sample buffer. If the buffer turns yellow, add Tris-HCl pH 8.8 until blue again.
Continue on to western blot protocol or freeze in -20˚C.

Western Blotting Protocol:
1. Load samples and MW markers (10 uL) on poly acrylamide gel. In each well: 15 ul of 15 ul
sample + 3 ul 6X SDS buffer mix (some will be left over but this allows for pipette error)
2. Boil samples at 95 degrees C for 5 mins
3. Do a gentle spindown to send any droplets remaining to the bottom.
4. Run samples on gel for desired time (standard 4h @80V)
5. Open the plates that hold the gel and gently remove the stacking gel and any unused lanes using a
razor blade.
-Make sure you can see the MW marker.
6. Make transfer buffer
100 mL10 X transfer buffer
100 mL MeOH (this is dangerous stuff!)
800 mL H20
1L
7. Make the sandwich:
a. Cut 2 pieces of Whatman (filter) paper and one piece of nitrocellulose
-Use gloves,
fingerprints will ruin your data.
-Snip the corner above the MW marker on both the gel and nitrocellulose so you can keep
track of the orientation throughout the protocol.
b. Pour some transfer buffer into a shallow dish and put down 1 layer of filter paper.
-Avoid trapping any air bubbles at any step after this.
c. VERY gently ease the gel from the glass plate onto the filter paper.
d. Nudge the gel into position, keeping everything under the buffer the whole time.
e. Gently lay the nitrocellulose on top.
-The gel and nitrocellulose cling to each other so don’t plan to do any adjustments after
you lay the nitrocellulose down. You still can it’s just a pain and you might damage the gel.
f.

Cover with the final piece of filter paper.
-Do a final check for air bubbles

g. Place the sandwich in the Western cassette, between the two sponges.
a. Remember: The nitrocellulose MUST be on the side that faces the cathode.
b. The final order should be:
Cathode; cassette; sponge; paper; nitrocellulose; gel; paper; sponge; cassette;
anode.
-If you aren’t 100% confident you did this step right it’s ok to take it out of the cassette
and check.
8. Run the western overnight at 10 V for 10-12 hours with a stir bar and ice pack in the container.
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9.
10.
11.
12.
13.

Remove the membrane and check that the pre-stained markers transferred.
Stain the nitrocellulose membrane with Ponceau S for ~5 minutes.
Rinse briefly with water and mark the sites of MW markers with a pencil.
Cut the nitrocellulose down as much as possible without cutting your sample.
Make up 5% nonfat milk solution in TBS-T.
-Make sure milk is homogenous or it will ruin the protein.

14. Block the membrane in the milk solution for ~10 minutes. (optional)
15. Wash the membrane 3 times with TBS-T to remove extra milk.
16. Probe the western overnight using PRIMARY antibodies (mouse anti-GFP) at a 1:1000 dilution.
This should be done in the cold room with moderate shaking.
-When inserting the western into the 15 mL falcon tube, avoid crinkling it by loosely
rolling it up, placing a corner in the tube, then as simultaneously insert and roll the
western into the falcon tube.
17. Wash the membrane 3X10 minutes with TBS-T, at room temperature.
18. Probe the membrane with SECONDARY antibody (anti-mouse HRP) at 1:10,000 in TBS-T + 5%
(w/v) milk. Do in the cold room with moderate shaking for 1.5-4 hours.
-Ideal if you can use a flat container for this
19. Wash the membrane 3X10 minutes with TBS-T.
20. Mix Pierce ECL (Femto) solutions 1:1 in a microfuge tube. (0.5 mL each).
21. Apply the ECL reagent to the membrane while the imager is warming up (2-5 min incubation at
RT).
22. Take pictures for 30 sec to 5 min, as necessary. BE SURE TO GET AN IMAGE OF THE MW
MARKERS.
23. Print images and save the TIFF files to the server for further processing.

Plasmid Integration Protocol:
C. elegans Transgene Integration, adapted from Darrell Killian,
https://personalwebs.coloradocollege.edu/~dkillian/Home/Transgene_Integration.html
“When transgenes are injected into the C. elegans germ line, the resultant transgenic animals carry the
transgenes as extrachromosomal arrays. Extrachromosomal arrays not always transmitted to the next
generation and often the transgenic animals are mosaic; they have some cells with the array and some
without. In some cases the transgenes must be stably integrated into the genome before they can be
reliably evaluated. This protocol is for using UV irradiation to cause double-stranded breaks in the
genome and the endogenous DNA repair mechanisms will sometimes insert the extrachromosomal array
into the genome.”
1. Pick about 150 L4 transgenic animals to one (or several) NGM plates without bacteria. David Fay
(University of Wyoming) reports that OP50 bacteria acts like sunscreen and lowers the dosage of UV
irradiation experienced by the worms.
2. Remove the lids (they block UV) and place into the UV Stratalinker 1800 with the open side facing up.
3. Program the FB UVXC-1000 to deliver 30,000 micro joules (300 x 100 uj) of energy: Press
“ENERGY”, press 3-0-0, and then press “START”. It should take about 20-30 seconds and beep when it
is done. The FB UVXC-1000 has 5 bulbs calibrated to 265 nm.
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4. Place 5 irradiated L4 animals on each of up to 30 OP50-seeded NGM plates. Use all of the irradiated
worms.
5. Let the worms starve out those plates. Note that some of these plates will not starve out due to the
irradiated animals either dying or becoming sterile. It may take several days longer than expected to
starve out the plates since the worms will be unhealthy.
6. Chunk each starved plate onto a seed plate and label it so it can be traced back to the original plate. For
example: Label a starved plate as “1” and chunk onto a new plate labeled “1a”.
7. 1-2 days after chunking, single 5 transgenic L4 animals to 5 seeded NGM plates (one per plate). Also
label these plates so they can be traced back to the original chunked plate. For example: From plate “4a”,
label the 5 plates made from this plate as “4a-1”, “4a-2”, “4a-3” etc.....
8. About 4 days later examine each plate and select plates with 100% transgenics and throw out any plates
with non-transgenic offspring. If you get more than one plate with 100% transgenics from the same
parent plate (that was chunked) they are probably not separate integration events unless they map to
different chromosomes. Generally only keep one independent integration event. The rate of integration
is 0-5%.
9. After an integrated line is established, it must be given a new allele designation and frozen as a new
strain. Also, since UV irradiation causes DNA damage, the strain must be outcrossed several times to
remove any background mutations.

Microscopic Imaging Protocol:
SLIDE PREPARATION (In Dahlberg lab using 2,3-butanedione monoxine, BDM)
1) Turn on heat block to 50-60 ˚C
2) Melt 2% (w/v) agarose in ddH2O in the microwave. Transfer some of the agarose into a glass tube
and place on the heat block. Cover the vial with a piece of aluminum foil. Melted agarose is good
for one day on the heat block.
3) Quickly, pipet ~2 drops of the agarose onto a glass slide and cover the droplet with another glass
slide. This will produce a thin agarose pad. If the agarose solidified too quickly, wipe it off with a
Kim-wipe and try again. Try to minimize bubbles. Worms like to aggregate around bubbles and
are no good for imaging. Allow the pad to dry for ~2 minutes.
4) In an Eppendorph tube, Make up a solution of 30 mg/mL BDM in M9 (i.e. 0.006 grams BDM in
200 µL M9). This solution is good for one day on ice.
5) On the dissecting microscope stage, place 4-5 µL of the BDM solution onto a glass cover slip,
and cover with a 60 mm petri-dish to prevent the liquid from evaporating.
6) Pick ~20 worms and swish the tip of pick in the BDM drop to dislodge worms. Return the petri
dish cover, and allow worms to paralyze for 5-6 minutes.
7) Once worms are paralyzed, place the glass slide with the agarose pad on top of the BDM drop.
The slide and the cover slip should adhere and you can remove the slide with the cover slip from
the stage. Remove excess liquid with a Kim-wipe.
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IMAGING (Leica DMi6000 inverted microscope)
1) BE CAREFUL. This is a $50k piece of equipment, and the 63x objective alone cost $7k
2) Remove microscope cover, make sure that the objective that pointed up is at 40X or lower (it
should always be returned to 10x at the end of imaging)
a. If the objective was left at a higher magnification (63x or 100x), remove the detachable
slide stage before turning on the microscope
3) Turn on the microscope computer, fluorescence box (if needed), and the microscope control box.
Allow the stage to calibrate.
4) Turn on the computer and open the Leica LASX software for the configuration:
a. Choose DefaultDynamicWidefieldTree if taking images
b. Choose SimulatorAF6000 if you do not want to connect to the microscope and just want
to use the software
5) At 10x magnification in DIC optics, place the slide in the mount with the glass cover slip facing
down
a. Place the glass slide all the way to one side of the mount. This way, if you have to take it
off and back on, the location of your worms in mark and find will be the same
6) At 40x magnification, focus the edges of the pharynx and mark the location. Move to the anterior
of the worm, and focus so that the edges of the worm are in focus. Repeat for all worms on slide.
7) Once the position of all worms are marked, move the stage, move the objective all the way down,
and switch to the 63x objective. Carefully put one drop of immersion oil onto the lens of the
objective.
8) Move the slide back over the objective lens, and move to the first marked location.
9) Imaging:
a. Set one channel to blue fluorescent light to capture GFP, using a 0.5 second exposure.
b. Set a second channel to green fluorescent light to capture RFP, setting an appropriate
exposure length with the over/under setting.
c. Set a third channel to DIC, setting an appropriate exposure length with the over/under
setting.
10) Take images of all marked locations, being mindful of photo-bleaching the GFP.
11) When you are done, clean and dry objective lenses and return the turret to 10x.
12) Put on the cover

